104 related articles for article (PubMed ID: 11719449)
21. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
22. Ras-dependent oncolysis with an adenovirus VAI mutant.
Cascalló M; Capellà G; Mazo A; Alemany R
Cancer Res; 2003 Sep; 63(17):5544-50. PubMed ID: 14500393
[TBL] [Abstract][Full Text] [Related]
23. Replication of herpes simplex virus 1 depends on the gamma 134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection.
Jing X; Cerveny M; Yang K; He B
J Virol; 2004 Jul; 78(14):7653-66. PubMed ID: 15220440
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene.
Park JS; Yang JM; Min MK
Biochem Biophys Res Commun; 2000 Jan; 267(2):581-7. PubMed ID: 10631105
[TBL] [Abstract][Full Text] [Related]
25. Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype.
Fu X; Zhang X
Cancer Res; 2002 Apr; 62(8):2306-12. PubMed ID: 11956088
[TBL] [Abstract][Full Text] [Related]
26. [Effect of influenza virus NS1 protein on host cell].
Zhao L; Zhang Y; Yang Z; Xu L; Yang Y; Yu M; Wang R; Zhou X; Huang P
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1912-7. PubMed ID: 19256338
[TBL] [Abstract][Full Text] [Related]
27. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
Trottier MD; Palian BM; Reiss CS
Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
Aghi M; Rabkin SD; Martuza RL
Cancer Res; 2007 Jan; 67(2):440-4. PubMed ID: 17234749
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways.
Barchet W; Krug A; Cella M; Newby C; Fischer JA; Dzionek A; Pekosz A; Colonna M
Eur J Immunol; 2005 Jan; 35(1):236-42. PubMed ID: 15593126
[TBL] [Abstract][Full Text] [Related]
30. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
[TBL] [Abstract][Full Text] [Related]
32. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
33. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway.
Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W
Virology; 2006 Mar; 347(1):52-64. PubMed ID: 16378631
[TBL] [Abstract][Full Text] [Related]
34. Influenza A virus inhibits cytoplasmic stress granule formation.
Khaperskyy DA; Hatchette TF; McCormick C
FASEB J; 2012 Apr; 26(4):1629-39. PubMed ID: 22202676
[TBL] [Abstract][Full Text] [Related]
35. NS1 protein of influenza A virus down-regulates apoptosis.
Zhirnov OP; Konakova TE; Wolff T; Klenk HD
J Virol; 2002 Feb; 76(4):1617-25. PubMed ID: 11799156
[TBL] [Abstract][Full Text] [Related]
36. NF90 is a novel influenza A virus NS1-interacting protein that antagonizes the inhibitory role of NS1 on PKR phosphorylation.
Li T; Li X; Zhu W; Wang H; Mei L; Wu S; Lin X; Han X
FEBS Lett; 2016 Aug; 590(16):2797-810. PubMed ID: 27423063
[TBL] [Abstract][Full Text] [Related]
37. Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis.
Jansen B; Schlagbauer-Wadl H; Eichler HG; Wolff K; van Elsas A; Schrier PI; Pehamberger H
Cancer Res; 1997 Feb; 57(3):362-5. PubMed ID: 9012455
[TBL] [Abstract][Full Text] [Related]
38. The Ebola virus VP35 protein functions as a type I IFN antagonist.
Basler CF; Wang X; Mühlberger E; Volchkov V; Paragas J; Klenk HD; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12289-94. PubMed ID: 11027311
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
J Virol; 2012 Nov; 86(22):12341-50. PubMed ID: 22951840
[TBL] [Abstract][Full Text] [Related]
40. Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells.
Efferson CL; Tsuda N; Kawano K; Nistal-Villán E; Sellappan S; Yu D; Murray JL; García-Sastre A; Ioannides CG
J Virol; 2006 Jan; 80(1):383-94. PubMed ID: 16352563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
